Protagenic Therapeutics, Inc. (PTIX)
0.4205
-0.05
(-10.94%)
USD |
OTCM |
Feb 20, 15:59
Protagenic Therapeutics Shareholders Equity (Quarterly) : -4.701M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Vanda Pharmaceuticals, Inc. | 327.19M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.003M |
| Total Liabilities (Quarterly) | 9.703M |
| Debt to Equity Ratio | -0.8504 |
| Current Ratio | 0.2946 |
| Net Debt Paydown Yield | -39.57% |